News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Health Canada approves Moderna's mRESVIA, a single-dose mRNA vaccine against RSV for adults aged 60 and older in a convenient pre-filled syringe. The vaccine's approval follows successful Phase 3 trial ConquerRSV -